American Scientist Wins 2019 Eppendorf & Science Prize

23-Oct-2019 - Germany

Dr. Orefice found that peripheral somatosensory neurons – neurons outside the brain that control the sense of touch – are key areas where autism-associated gene mutations have a critical impact. She showed how abnormal function of peripheral somatosensory neurons causes touch over-reactivity and how this over-reactivity during development contributes to altered brain function and some autism-related behaviors in mice. Dr. Orefice’s work changes how we think about the causes of ASD, providing a surprising revision of widely-held views that link ASD exclusively to brain function. She highlights peripheral somatosensory neurons as a possible novel therapeutic target for improving some ASD-related symptoms.

Dr. Orefice

Dr. Orefice

The annual US$25,000 Eppendorf & Science Prize for Neurobiology honors scientists, like Dr. Orefice, for their ground-breaking research. Lauren Orefice is the 18th recipient of this international prize which is awarded jointly by Eppendorf and the journal Science. Researchers who are 35 years of age or younger and have made outstanding contributions to neurobiological research based on methods of molecular and cell biology are invited to apply. The next deadline for applications is June 15, 2020.

Other news from the department science

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Category:Types_of_cancer

A breakthrough in understanding COVID-19 proteins - Researchers have released a revolutionary database for molecular dynamics simulations

A breakthrough in understanding COVID-19 proteins - Researchers have released a revolutionary database for molecular dynamics simulations

In neurodegenerative diseases, brain immune cells have a “ravenous appetite” for sugar - The interpretation of certain brain scans needs rethinking

In neurodegenerative diseases, brain immune cells have a “ravenous appetite” for sugar - The interpretation of certain brain scans needs rethinking

Spermidine as a Potential Biomarker for Alzheimer’s Disease - New insights into the role of the polyamine spermidine in brain ageing

Spermidine as a Potential Biomarker for Alzheimer’s Disease - New insights into the role of the polyamine spermidine in brain ageing

Captain T Cell secures seed financing round - Start-up develops first-in-class efficacy-enhanced TCR-T cells for solid tumors that are not addressed by existing therapies

Captain T Cell secures seed financing round - Start-up develops first-in-class efficacy-enhanced TCR-T cells for solid tumors that are not addressed by existing therapies

Merck and Washington University working on diagnostics and treatment of malnutrition - Genome editing to be used in intestinal bacteria research

Researchers could use plant's light switch to control cells

Biodegradable composites - A significant advance in medical implant technology

Biodegradable composites - A significant advance in medical implant technology

Stimulating the Immune System to Fight Cancer - Scientists find immunoregulatory substances with newly developed test system

Stimulating the Immune System to Fight Cancer - Scientists find immunoregulatory substances with newly developed test system

Swimming upstream on sound waves - Tiny vehicles are set to be introduced into the human bloodstream, thereby revolutionising the field of medicine

Swimming upstream on sound waves - Tiny vehicles are set to be introduced into the human bloodstream, thereby revolutionising the field of medicine

QIAGEN Expands Partnership with Genome Diagnostics for Development of Tests in Prevention and Personalized Healthcare - Extended HLA testing portfolio includes products to assess tolerance for Lumiracoxib and for the early detection of inflammatory diseases

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs